3 results on '"Wiebringhaus H"'
Search Results
2. Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer : a subanalysis of data from the randomized phase III GeparSepto trial
3. nab-paclitaxel at a dose of 125 mg/m(2) weekly is more efficacious but less toxic than at 150 mg/m(2) : Results from the neoadjuvant randomized GeparSepto study (GBG 69)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.